Gloria Donnelly, 79, left, who has Alzheimer's disease, has blood drawn from Megan Holt before being given an infusion of Anti-Amloid Beta Monoclonal Antibody, a trial drug used for potentially slowing the progression of the disease. Donnelly is enrolled in a clinical trial conducted at Neuropsychiatric Research Center of Southwest Florida in Fort Myers. There is a fifty per cent possibility that Donnelly will receive a placebo. A new national program, Community Alzheimer's Research Exchange for Patients and Caregivers, CAREPAC, is spearheading a 20-region project to boost enrollment in Alzheimer's clinical drug trials. Lexey Swall/Staff

Photo by LEXEY SWALL

Gloria Donnelly, 79, left, who has Alzheimer's disease, has blood drawn from Megan Holt before being given an infusion of Anti-Amloid Beta Monoclonal Antibody, a trial drug used for potentially slowing the progression of the disease. Donnelly is enrolled in a clinical trial conducted at Neuropsychiatric Research Center of Southwest Florida in Fort Myers. There is a fifty per cent possibility that Donnelly will receive a placebo. A new national program, Community Alzheimer's Research Exchange for Patients and Caregivers, CAREPAC, is spearheading a 20-region project to boost enrollment in Alzheimer's clinical drug trials. Lexey Swall/Staff

Buy this photo

Photo Rating:

Comments » 0

Be the first to post a comment!

Share your thoughts

Comments are the sole responsibility of the person posting them. You agree not to post comments that are off topic, defamatory, obscene, abusive, threatening or an invasion of privacy. Violators may be banned. Click here for our full user agreement.

Comments can be shared on Facebook and Yahoo!. Add both options by connecting your profiles.

Features